Global Osteoarthritis Therapeutics Market Size & Outlook
Global osteoarthritis therapeutics market, 2021-2033 (US$M)
Related Markets
Global osteoarthritis therapeutics market highlights
- The global osteoarthritis therapeutics market generated a revenue of USD 5,485.9 million in 2025 and is expected to reach USD 10,891.7 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 8.9% by 2033.
- In terms of segment, viscosupplements accounted for a revenue of USD 2,880.9 million in 2025.
- Other (Cartilage Resurfacing Products) is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, Canada is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 5,485.9 million |
| Market revenue in 2033 | USD 10,891.7 million |
| Growth rate | 8.9% (CAGR from 2026 to 2033) |
| Largest segment | Viscosupplements |
| Fastest growing segment | Other (Cartilage Resurfacing Products) |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Platelet-Rich Plasma (PRP) Therapy, Autologous Chondrocyte Implantation (ACI), Including MACI, Adipose Tissue Therapy, BMAC (Bone Marrow Aspirate Concentrate) Therapy, Stem Cell (other), Bone Graft Substitutes, Viscosupplements, Other (Cartilage Resurfacing Products) |
Other key industry trends
- In terms of revenue, the North America accounted for 48.1% of the global osteoarthritis therapeutics market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, Canada is the fastest growing regional market and is projected to reach USD 343.4 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Osteoarthritis Therapeutics Market Scope
Osteoarthritis Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Assertio Holdings Inc | View profile | 30 | 100 South Saunders Road, Suite 300, Lake Forest, IL, United States, 60045 | https://www.assertiotx.com |
| GlaxoSmithKline Consumer Healthcare (GSK CH India) | View profile | 1001-5000 | Gurgaon, Haryana, India, Asia | https://india-consumer.gsk.com/ |
| Bioventus Inc Class A | View profile | 995 | 4721 Emperor Boulevard, Suite 100, Durham, NC, United States, 27703 | https://www.bioventus.com |
| Anika Therapeutics Inc | View profile | 357 | 32 Wiggins Avenue, Bedford, MA, United States, 01730 | https://www.anika.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Zimmer Biomet Holdings Inc | View profile | 18000 | 345 East Main Street, Warsaw, IN, United States, 46580 | https://www.zimmerbiomet.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Global osteoarthritis therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to osteoarthritis therapeutics market will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 52.51% in 2025. Horizon Databook has segmented the Global osteoarthritis therapeutics market based on platelet-rich plasma (prp) therapy, autologous chondrocyte implantation (aci), including maci, adipose tissue therapy, bmac (bone marrow aspirate concentrate) therapy, stem cell (other), bone graft substitutes, viscosupplements, other (cartilage resurfacing products) covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Osteoarthritis Therapeutics Product Outlook (Revenue, USD Million, 2021-2033)
- Platelet-Rich Plasma (PRP) Therapy
- Autologous Chondrocyte Implantation (ACI), Including MACI
- Adipose Tissue Therapy
- BMAC (Bone Marrow Aspirate Concentrate) Therapy
- Stem Cell (other)
- Bone Graft Substitutes
- Viscosupplements
- Other (Cartilage Resurfacing Products)
- Global Osteoarthritis Therapeutics Application Outlook (Revenue, USD Million, 2021-2033)
- Knee Osteoarthritis
- Platelet-Rich Plasma (PRP) Therapy
- Autologous Chondrocyte Implantation (ACI), Including MACI
- Adipose Tissue Therapy
- BMAC (Bone Marrow Aspirate Concentrate) Therapy
- Stem Cell (other)
- Bone Graft Substitutes
- Viscosupplements
- Other (Cartilage Resurfacing Products)
- Hip Osteoarthritis
- Platelet-Rich Plasma (PRP) Therapy
- Autologous Chondrocyte Implantation (ACI), Including MACI
- Adipose Tissue Therapy
- BMAC (Bone Marrow Aspirate Concentrate) Therapy
- Stem Cell (other)
- Bone Graft Substitutes
- Viscosupplements
- Other (Cartilage Resurfacing Products)
- Shoulder Osteoarthritis
- Platelet-Rich Plasma (PRP) Therapy
- Autologous Chondrocyte Implantation (ACI), Including MACI
- Adipose Tissue Therapy
- BMAC (Bone Marrow Aspirate Concentrate) Therapy
- Stem Cell (other)
- Bone Graft Substitutes
- Viscosupplements
- Other (Cartilage Resurfacing Products)
- Spine Osteoarthritis
- Platelet-Rich Plasma (PRP) Therapy
- Autologous Chondrocyte Implantation (ACI), Including MACI
- Adipose Tissue Therapy
- BMAC (Bone Marrow Aspirate Concentrate) Therapy
- Stem Cell (other)
- Bone Graft Substitutes
- Viscosupplements
- Other (Cartilage Resurfacing Products)
- Ankle & Foot Osteoarthritis
- Platelet-Rich Plasma (PRP) Therapy
- Autologous Chondrocyte Implantation (ACI), Including MACI
- Adipose Tissue Therapy
- BMAC (Bone Marrow Aspirate Concentrate) Therapy
- Stem Cell (other)
- Bone Graft Substitutes
- Viscosupplements
- Other (Cartilage Resurfacing Products)
- Other
- Platelet-Rich Plasma (PRP) Therapy
- Autologous Chondrocyte Implantation (ACI), Including MACI
- Adipose Tissue Therapy
- BMAC (Bone Marrow Aspirate Concentrate) Therapy
- Stem Cell (other)
- Bone Graft Substitutes
- Viscosupplements
- Other (Cartilage Resurfacing Products)
- Knee Osteoarthritis
- Global Osteoarthritis Therapeutics Primary User Outlook (Revenue, USD Million, 2021-2033)
- Orthopedic Surgeons
- Rheumatologists
- Sports Medicine Specialists
- Regenerative Medicine Specialists
- Other
Reasons to subscribe to Global osteoarthritis therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global osteoarthritis therapeutics market databook
-
Our clientele includes a mix of osteoarthritis therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global osteoarthritis therapeutics market , including forecasts for subscribers. This global databook contains high-level insights into Global osteoarthritis therapeutics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global osteoarthritis therapeutics market size, by regions, 2021-2033 (US$M)
Top 10 countries: Osteoarthritis therapeutics market size, 2023 (US$M)
Global osteoarthritis therapeutics market share, by route of administration, 2023 & 2030 (%, US$M)
Osteoarthritis therapeutics market: Opportunity assessment by country
Global osteoarthritis therapeutics market, by region, 2025 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
